Announcements Trials
Browse Landscape

Phase

Phase NA 9Phase 2 3Phase 1 3Phase EARLY_PHASE1 2Phase 2/3 2Phase 1/2 2Phase 4 1Phase 3 1

Status

Completed 14Terminated 4Recruiting 4Unknown 3Active not recruiting 2Withdrawn 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 3

Conditions

Neoplasms 85Carcinoma, Non-Small-Cell Lung 75Breast Neoplasms 73Recurrence 64Colorectal Neoplasms 62Pancreatic Neoplasms 59Multiple Myeloma 57Melanoma 56Carcinoma, Hepatocellular 56Advanced Solid Tumor 55Leukemia, Myeloid, Acute 53Advanced Solid Tumors 53Lymphoma 52Neoplasm Metastasis 50Stomach Neoplasms 45Precursor Cell Lymphoblastic Leukemia-Lymphoma 44Solid Tumor 39Lymphoma, B-Cell 39Ovarian Neoplasms 38Lymphoma, Non-Hodgkin 37Lung Neoplasms 35Glioblastoma 35Prostatic Neoplasms 34Leukemia 28Head and Neck Neoplasms 27Leukemia, Lymphocytic, Chronic, B-Cell 26Uterine Cervical Neoplasms 25Burkitt Lymphoma 24Esophageal Neoplasms 22Urinary Bladder Neoplasms 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Unknown × Bone Neoplasms × Clear all
NCT06008483 2023-08-23

A Dose Finding Study to Treat Bone Tumor(s)

QSAM Therapeutics, Inc.

Phase 1 Unknown
17 enrolled
Sarcoma

Bone Neoplasms

NCT03462316 2023-04-12

NY-ESO-1-specific T Cell Receptor (TCR) T Cell in Sarcoma

Sun Yat-sen University

Phase 1 Unknown
20 enrolled
Sarcoma

Bone Neoplasms, Sarcoma

NCT04178044 2019-11-26

Phase â…  Clinical Study Protocol of GB223 Monoclonal Antibody Injection

Genor Biopharma Co., Ltd.

Phase 1 Unknown
44 enrolled
Sarcoma

Bone Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡